Global NEUROSCIENCE ANTIBODIES AND ASSAYS Market Size Study by Product (Reagent, Instruments), Technology (Immunoassay, Molecular Diagnostics), End User (Research Institute, Hospital), and Regional Forecasts 2017-2025

June 2018 | 120 pages | ID: GD5EEBA388EEN
Bizwit Research & Consulting LLP

Abstracts

Global NEUROSCIENCE ANTIBODIES AND ASSAYS Market to reach USD 5.1 billion by 2025.

Global NEUROSCIENCE ANTIBODIES AND ASSAYS Market valued approximately USD 2.1 billion in 2016 is anticipated to grow with a healthy growth rate of more than 10.3% over the forecast period 2017-2025. The increasing automation of high-throughput screening and the availability of robust data management software tools, which enable researchers to develop systemic and process-oriented approaches toward neuroscience antibodies and assays techniques are some of the factors contributing to the growth of this segment.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product

Reagents

Instruments
By Technology

• Immunoassay
• Molecular Diagnostics

By End User

• Research Institutes
• Hospitals

By Regions:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• China
• India
• Japan
• Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2015
Base year – 2016
Forecast period – 2017 to 2025

Some of the key manufacturers involved in the market are. Thermo Fisher Scientific, Abcam, Bio-Rad, Merck KGAA, Cell Signaling Technology, Genscript, Rockland Immunochemicals. Bio Legend, Santa Cruz Biotechnology, Tecan, F. Hoffmann-La Roche, Siemens. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.

Target Audience of the Global NEUROSCIENCE ANTIBODIES AND ASSAYS in Market Study:

• Key Consulting Companies & Advisors
• Large, medium-sized, and small enterprises
• Venture capitalists
• Value-Added Resellers (VARs)
• Third-party knowledge providers
• Investment bankers
• Investors

Contents

CHAPTER 1. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET DEFINITION AND SCOPE

1.1. Research Objective
1.2. Market Definition
1.3. Scope of The Study
1.4. Years Considered for The Study
1.5. Currency Conversion Rates
1.6. Report Limitation

CHAPTER 2. RESEARCH METHODOLOGY

2.1. Research Process
  2.1.1. Data Mining
  2.1.2. Analysis
  2.1.3. Market Estimation
  2.1.4. Validation
  2.1.5. Publishing
2.2. Research Assumption

CHAPTER 3. EXECUTIVE SUMMARY

3.1. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
3.2. Key Trends

CHAPTER 4. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET DYNAMICS

4.1. Growth Prospects
  4.1.1. Drivers
  4.1.2. Restraints
  4.1.3. Opportunities
4.2. Industry Analysis
  4.2.1. Porter’s 5 Force Model
  4.2.2. PEST Analysis
  4.2.3. Value Chain Analysis
4.3. Analyst Recommendation & Conclusion

CHAPTER 5. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET, BY PRODUCT

5.1. Market Snapshot
5.2. Market Performance - Potential Model
5.3. Global NEUROSCIENCE ANTIBODIES AND ASSAYS Market, Sub Segment Analysis
  5.3.1. Reagents
    5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  5.3.2. Instruments
    5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 6. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET, BY APPLICATION

6.1. Market Snapshot
6.2. Market Performance - Potential Model
6.3. Global NEUROSCIENCE ANTIBODIES AND ASSAYS Market, Sub Segment Analysis
  6.3.1. Immunoassay
    6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.3.2. Molecular Diagnostics
    6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 7. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET, BY END-USER

7.1. Market Snapshot
7.2. Market Performance - Potential Model
7.3. Global NEUROSCIENCE ANTIBODIES AND ASSAYS Market, Sub Segment Analysis
  7.1.1. Research Institutes
    7.1.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.1.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  7.1.2. Hospitals
    7.1.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.1.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 8. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET, BY REGIONAL ANALYSIS

8.1. NEUROSCIENCE ANTIBODIES AND ASSAYS Market, Regional Market Snapshot (2015-2025)
8.2. North America NEUROSCIENCE ANTIBODIES AND ASSAYS Market Snapshot
  8.2.1. U.S.
    8.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.2.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.2.1.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.2.1.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.2.2. Canada
    8.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.2.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.2.2.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.2.2.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3. Europe NEUROSCIENCE ANTIBODIES AND ASSAYS Market Snapshot
  8.3.1. U.K.
    8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.1.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.1.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.3.2. Germany
    8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.2.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.2.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.3.3. France
    8.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.3.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.3.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.3.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.3.4. Rest of Europe
    8.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.4.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.4.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.4.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4. Asia NEUROSCIENCE ANTIBODIES AND ASSAYS Market Snapshot
  8.4.1. China
    8.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.4.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.1.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.1.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.4.2. India
    8.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.4.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.2.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.2.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.4.3. Japan
    8.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.4.3.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.3.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.3.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.4.4. Rest of Asia Pacific
    8.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.4.4.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.4.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.4.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5. Rest of The World
  8.5.1. South America
    8.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.5.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.1.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.1.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.5.2. Middle East and Africa
    8.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.5.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.2.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.2.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 9. COMPETITIVE INTELLIGENCE

9.1. Company Market Share (Subject to Data Availability)
9.2. Top Market Strategies
9.3. Company Profiles
  9.3.1. Thermo Fisher Scientific Inc.
    9.3.1.1. Overview
    9.3.1.2. Financial (Subject to Data Availability)
    9.3.1.3. Product Summary
    9.3.1.4. Recent Developments
  9.3.2. Abcam
  9.3.3. Bio-Rad
  9.3.4. Merck KGaA
  9.3.5. Cell Signaling Technology
  9.3.6. Genscript
  9.3.7. Rockland Immunochemicals
  9.3.8. BioLegend
  9.3.9. Santa Cruz Biotechnology
  9.3.10. Tecan
  9.3.11. F. Hoffmann-La Roche
  9.3.12. Siemens